Related Experiment Videos
Platelet function abnormalities in a family with recurrent arterial thrombosis
Surgery
|February 1, 1978
Summary
Familial hypercoagulability may be linked to abnormally sensitive platelets, causing recurrent arterial thrombosis. Antiplatelet drug therapy showed success in affected family members.
Area of Science:
- Hematology
- Vascular Biology
- Genetics
Background:
- Recurrent arterial thrombosis in young individuals necessitates investigation into underlying causes.
- Standard lipid and coagulation tests often fail to identify the etiology of such thrombotic events.
Observation:
- Platelet function testing revealed enhanced platelet aggregability and serotonin release in response to agonists in two of three family members.
- The third subject exhibited decreased platelet aggregation, potentially due to ongoing in vivo thrombosis affecting ex vivo testing.
Findings:
- Abnormally sensitive platelets, identified through platelet function assays, suggest a familial hypercoagulability syndrome.
- This hypersensitivity involves increased platelet aggregation and serotonin release, indicating a prothrombotic state.
Implications:
- Identifying specific hemostatic abnormalities provides a rationale for targeted pharmacological interventions.
- Antiplatelet drug therapy demonstrated efficacy in managing thrombosis associated with this familial platelet disorder.